ArticleJournal of managed care & specialty pharmacy2022

Cost-effectiveness of direct-acting antivirals for chronic hepatitis C virus in the United States from a payer perspective.

David E Kaplan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.